Release date: 2007-05-15 Italy has introduced a groundbreaking implantable left ventricular assist device (LVAD) designed to significantly improve the quality of life for patients suffering from severe heart failure. This innovative system, called BestBeat, offers more natural and physiological support by working in sync with the heart's own function. Unlike traditional devices, it automatically counter-pulses with the left ventricle, reducing the workload on the heart and enhancing its ability to handle physical activity and metabolic demands. The BestBeat system is capable of adapting to changes in the left ventricular afterload, ensuring that it meets the varying needs of each patient. It maintains synchronized counterpulsation throughout the process, which helps keep the heart muscle in a state of rest while still providing adequate blood flow. This feature makes it especially effective for long-term support during graft bypass or recovery phases. The adjustable load also allows doctors to better manage the weaning process, ensuring a smooth transition without compromising circulation. Developed by NewCortec in Rome, Italy, with technical collaboration from ET Medical Devices in Cavareno, Italy, the BestBeat system is currently undergoing clinical trials in France and Germany. These trials are an important step toward broader adoption and could potentially revolutionize the treatment of advanced heart failure. As medical technology continues to evolve, innovations like this bring new hope to patients and healthcare professionals alike. ——Shanghai Medical Device Industry Association good fresh frozen octopus Delicious Sliced Octopus,Frozen Flower Octopus,Fresh Flower Octopus,Flower Frozen Octopus Zhoushan Junwei Aquatic Products Co., Ltd. , https://www.junweiaquatic-intl.com
Italy developed a new type of LVAD to help the diseased heart beat better
Next Article
Black peanut planting technology